This guideline outlines the importance of Medicaid 1115 waivers and pre-release healthcare coverage in improving access to hepatitis C (HCV) treatment for incarcerated individuals. It discusses how expanding Medicaid coverage can enhance continuity of care, reduce transmission, and support reentry populations.

This fact sheet provides critical guidance for healthcare providers on managing patients with hepatitis C virus (HCV). It outlines key steps for diagnosis, treatment, and referral, emphasizing the importance of early detection and timely intervention. The fact sheet aims to equip healthcare providers with essential tools and resources to improve patient outcomes and prevent the spread of HCV through effective care strategies.

This report outlines the progress made toward the elimination of mother-to-child transmission of hepatitis B virus in the Region of the Americas from 2012 to 2022. It highlights key strategies, achievements, and challenges in achieving the goal of reducing the transmission rates, providing a comprehensive overview of regional efforts to combat this public health issue.

This webpage provides the Vaccine Information Statement (VIS) for the hepatitis B vaccine, detailing the vaccine's purpose, the diseases it prevents, the recommended vaccination schedule, potential side effects, and important information for healthcare providers. It serves as an essential resource for understanding the importance of hepatitis B vaccination.

This report proposes policies for expanding access to hepatitis C (HCV) testing and treatment in United States jails and prisons. The report's policy recommendations draw principally from settlement agreements, judicial opinions, and other filings in those cases, supplemented by current medical guidance and input from public health experts, medical professionals, and advocates.

This information sheet provides details on Doxy PEP (Post-Exposure Prophylaxis) as a preventive treatment for sexually transmitted infections (STIs), including syphilis, gonorrhea, and chlamydia. It outlines the necessary steps for individuals who have been exposed to an STI and may be eligible for doxycycline PEP.

This information sheet provides details on Doxy PEP (Post-Exposure Prophylaxis) as a preventive treatment for sexually transmitted infections (STIs), including syphilis, gonorrhea, and chlamydia. It outlines the necessary steps for individuals who have been exposed to an STI and may be eligible for doxycycline PEP.

This webpage provides information on early HIV-related mouth sores, including pictures to help with identification. It discusses common oral symptoms associated with early HIV infection, such as ulcers, thrush, and other lesions, and highlights their significance in early diagnosis.